Orchestra BioMed Holdings, Inc. Increase Decrease In Operating Lease Liability
Orchestra BioMed Holdings, Inc. (OBIO) reported Increase Decrease In Operating Lease Liability of -$359.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-10
- Orchestra BioMed Holdings, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$187.00K.
- Orchestra BioMed Holdings, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$172.00K.
- Orchestra BioMed Holdings, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$144.00K.
- Orchestra BioMed Holdings, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$139.00K.
- Orchestra BioMed Holdings, Inc. increase decrease in operating lease liability for fiscal 2025 was -$550.00K.
- Orchestra BioMed Holdings, Inc. increase decrease in operating lease liability for fiscal 2024 was -$652.00K.
- Orchestra BioMed Holdings, Inc. increase decrease in operating lease liability for fiscal 2023 was -$693.00K.
- Orchestra BioMed Holdings, Inc. increase decrease in operating lease liability for fiscal 2022 was -$319.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$187.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$359.00K 10-Q · filed 2026-08-10 | -$503.00K derived: sum of 3 quarters · filed 2026-08-10 | -$642.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$172.00K 10-Q · filed 2026-05-12 | -$316.00K derived: sum of 2 quarters · filed 2026-05-12 | -$455.00K derived: sum of 3 quarters · filed 2026-05-12 | -$590.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$283.00K derived: sum of 2 quarters · filed 2026-03-12 | -$418.00K derived: sum of 3 quarters · filed 2026-08-10 | -$550.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | -$139.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$274.00K derived: sum of 2 quarters · filed 2026-08-10 | -$406.00K 10-Q · filed 2025-11-10 | -$544.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$135.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$267.00K 10-Q · filed 2026-08-10 | -$405.00K derived: sum of 3 quarters · filed 2026-08-10 | -$684.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$132.00K 10-Q · filed 2026-05-12 | -$270.00K derived: sum of 2 quarters · filed 2026-05-12 | -$549.00K derived: sum of 3 quarters · filed 2026-05-12 | -$721.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$417.00K derived: sum of 2 quarters · filed 2026-03-12 | -$589.00K derived: sum of 3 quarters · filed 2026-03-12 | -$652.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | -$279.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$451.00K derived: sum of 2 quarters · filed 2025-11-10 | -$514.00K 10-Q · filed 2025-11-10 | -$691.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$172.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$235.00K 10-Q · filed 2025-08-12 | -$412.00K derived: sum of 3 quarters · filed 2025-08-12 | -$587.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$63.00K 10-Q · filed 2025-05-12 | -$240.00K derived: sum of 2 quarters · filed 2025-05-12 | -$415.00K derived: sum of 3 quarters · filed 2025-05-12 | -$587.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$177.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$352.00K derived: sum of 2 quarters · filed 2025-03-31 | -$524.00K derived: sum of 3 quarters · filed 2025-03-31 | -$693.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$175.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$347.00K derived: sum of 2 quarters · filed 2024-11-12 | -$516.00K 10-Q · filed 2024-11-12 | -$639.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$172.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$341.00K 10-Q · filed 2024-08-12 | -$464.00K derived: sum of 3 quarters · filed 2024-08-12 | -$612.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$169.00K 10-Q · filed 2024-05-13 | -$292.00K derived: sum of 2 quarters · filed 2024-05-13 | -$440.00K derived: sum of 3 quarters · filed 2024-05-13 | -$587.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$271.00K derived: sum of 2 quarters · filed 2024-03-27 | -$418.00K derived: sum of 3 quarters · filed 2024-03-27 | -$319.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | -$148.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$295.00K derived: sum of 2 quarters · filed 2023-11-13 | -$196.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | -$147.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$48.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $99.00K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |